• SENSEX 76,917.85
    1,225.07 (+1.62%)
  • BANKNIFTY 55,540.05
    537.85 (+0.98%)
  • NSE
    1,814.50 1,878.00(%)
  • Jio Platforms
    1,440.80 1,490.00(%)
  • Bharti Airtel
    2,080.70 2,174.70(%)
  • Reliance Industries
    1,307.00 1,611.20(%)
  • BLS Polymers
    285.25 285.25(%)
  • Solar Industries
    20,860.00 22,630.05(%)
  • Multi Comm. Exc.
    3,537.00 3,537.00(%)
  • Aegis Logistics
    1,253.90 1,528.00(%)
  • SBI
    961.35 933.85(%)
  • HDFC Bank
    725.70 1,017.90(%)
  • Oil India
    451.30 395.75(%)
  • Garden Reach Sh.
    2,235.00 3,338.90(%)
  • Divi's Lab.
    10,035.00 10,035.00(%)
  • M & M Fin. Serv.
    267.15 415.00(%)
  • Sagility
    41.98 35.82(%)
  • SFC Enviro.
    424.85 424.85(%)
  • Mankind Pharma
    2,523.70 2,640.30(%)
  • M & M
    2,910.95 3,840.00(%)
  • Kanohar Elect.
    1,165.90 1,210.00(%)
  • Laurus Labs
    2,252.50 913.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Sakar Healthcare Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 66415.0
  • ISIN : INE732S01012
944.55 10 (1.08%)
  • As on 04 Nov 2026 (EOD)

  • Today’s Low

    940.00

  • Today’s High

    969.90

  • Open

    950.00

  • Perv Close

    934.45

  • 52W Low

    352.50

  • 52W High

    1,229.85

Key Indicators

  • P/E(TTM)

    49.02

  • Mar.Cap (₹Cr.)

    2,101.62

  • Div & Yield %

    0.00

  • Book Value(₹)

    155.54

  • Debt-Equity Ratio

    1.08

  • AGM Date

    03-Nov-2026

  • EPS

    19.27

  • P/E Ratio

    49.02

Financials Ratios

  • Debt-Equity Ratio

    0.46

  • Mar.Cap (₹Cr.)

    2,101.62

  • RONW (%)

    5.36

  • ROCE (%)

    7.36

Score Board

  • Equity (₹ in Cr.)

    22.25

  • BV (₹)

    155.50

  • Sales( ₹ in Cr.)

    251.74

  • NP (in Cr.)

    30.48

  • NP Var(%)

    72.0

  • Div%

    0.0

  • CPS (₹)

    24.30

  • EPS (₹)

    13.70

  • Traded Value (₹ in Lakhs)

    2,101.62

  • 52 Week High

    1,229.85

  • 52 Week Low

    352.50

  • Price BSE

    0.0

  • Price NSE

    945.00

  • Market Capital( in Cr.)

    2,101.62

  • P/C Ratio

    38.90

  • P/E Ratio

    69.00

  • Price Vs.BV

    13.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 251.74 177.58 153.35 133.36 128.23 94.74
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 251.74 177.58 153.35 133.36 128.23 94.74
Other Income 2.29 1.31 3.18 4.67 2.17 1.18
Stock Adjustments 9.41 13.20 1.38 0.36 -0.93 0.91
Total Income 263.44 192.09 157.91 138.39 129.47 96.83
EXPENDITURE :            
Raw Materials 132.75 95.47 85.05 74.00 73.69 52.20
Power and Fuel Cost 6.38 5.15 4.25 2.90 3.01 2.26
Employee Cost 34.40 30.15 18.82 15.81 14.26 12.74
Other Manufacturing Expenses 2.22 0.36 0.74 0.69 0.95 0.90
Selling and Administration Expenses 15.58 8.91 6.92 6.85 5.70 4.11
Miscellaneous Expenses 0.94 1.12 0.57 0.34 0.28 0.84
Employee Benefit Expenses 34.40 30.15 18.82 15.81 14.26 12.74
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 192.26 141.16 116.36 100.58 97.89 73.04
Operating Profit 71.18 50.95 41.54 37.81 31.58 23.78
Interest 7.86 8.54 7.59 5.95 2.90 2.48
Gross Profit 63.32 42.41 33.95 31.86 28.68 21.30
Depreciation 23.56 20.88 18.05 14.99 9.67 8.06
Profit Before Tax 39.76 21.53 15.90 16.87 19.01 13.24
Current Tax 6.23 0.00 0.00 0.00 3.41 3.18
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 3.04 4.03 4.23 4.12 0.35 -0.63
Reported Net Profit 30.48 17.50 11.67 12.76 15.24 10.69
Extraordinary Items 0.00 -0.25 0.17 0.07 0.03 -0.11
Adjusted Net Profit 30.48 17.75 11.50 12.69 15.21 10.80
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 -0.75
P & L Balance brought forward 98.12 80.62 68.95 56.19 40.95 31.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 128.61 98.12 80.62 68.95 56.19 40.95
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 13.70 7.97 5.37 6.70 8.90 6.85
Earnings Per Share(Adj)-Unit Curr 13.70 7.97 5.37 6.70 8.90 6.85
Book Value 145.86 128.78 118.44 91.09 74.50 63.04
Book Value(Adj)-Unit Curr 145.86 128.78 118.44 91.09 74.50 63.04

Shareholding Pattern

  • Promoter Group

    51.70%

  • Public Share Holding

    48.30%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 11,503,918 51.70 11,503,918 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 11,503,918 51.70 11,503,918 4
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 2,745,409 12.34 2,745,409 14
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 2,651,278 11.92 2,651,278 12
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 5,396,687 24.25 5,396,687 26
2] Non Institution
Bodies Corporate 330,486 1.49 330,486 133
Clearing Members 18,548 0.08 18,548 14
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 258,811 1.16 258,811 431
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 183,782 0.83 183,782 398
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 740,993 3.33 740,993 16
Individuals holding nominal share capital up to Rs. 1 lakh 3,801,647 17.09 3,801,647 18,502
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 2 0.00 2 1
Sub Total 5,349,305 24.04 5,349,305 19,509
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 22,249,910 100.00 22,249,910 19,539

Company Background

Sakar Healthcare LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Sakar Healthcare Ltd
  • BSE Code : 66415.0
  • ISIN : INE732S01012

  • Incorporation Year

    2004

  • Registered Office

    10/13 Nr MN Desai Petrol Pump
    Sarkhej Bavla Highway, Changodar,
    Gujarat-382213

  • Telephone

    91-2717-250477

  • FAX

    91-2717-251621

  • Chairman

    Sanjay S Shah.

  • Managing Director

    Sanjay S Shah.

  • Company Secretary

    Bharat Soni

  • Auditor

    J S Shah & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime Pvt Ltd
    5th Floor 506 to 508,
    ABC-I Off C G Road,Navrangpura
    Mumbai - Ahmedabad-380009

Sakar Healthcare Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Sakar Healthcare 944.55 254.02 251.74 49.02 12.33
Abbott India 25,805.30 7,217.19 6,929.05 33.96 43.78
Astrazeneca Phar 6,340.60 2,304.07 2,275.58 93.45 27.86
Glaxosmi. Pharma 2,573.30 3,932.76 3,790.20 41.11 58.17
Novartis India 1,719.85 393.10 354.33 43.43 15.94
Cipla 1,392.20 20,102.60 18,979.95 42.43 13.88
Bliss GVS Pharma 637.90 773.53 729.81 41.58 12.51
Amrutanjan Healt 499.35 520.13 502.55 26.75 24.16
Fermenta Biotec. 427.55 474.15 450.25 19.96 18.77
Guj. Themis Bio. 377.25 168.25 165.82 100.87 18.05
Ambalal Sarabhai 34.90 19.52 3.94 64.63 6.77